Kohjin Bio Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 5/6

Kohjin Bio has a total shareholder equity of ¥3.3B and total debt of ¥2.2B, which brings its debt-to-equity ratio to 65.1%. Its total assets and total liabilities are ¥6.6B and ¥3.2B respectively. Kohjin Bio's EBIT is ¥597.0M making its interest coverage ratio 27.1. It has cash and short-term investments of ¥1.7B.

Anahtar bilgiler

65.1%

Borç/özkaynak oranı

JP¥2.18b

Borç

Faiz karşılama oranı27.1x
NakitJP¥1.73b
EşitlikJP¥3.34b
Toplam yükümlülüklerJP¥3.25b
Toplam varlıklarJP¥6.59b

Son finansal sağlık güncellemeleri

Güncelleme yok

Recent updates

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: 177A's short term assets (¥3.4B) exceed its short term liabilities (¥2.4B).

Uzun Vadeli Yükümlülükler: 177A's short term assets (¥3.4B) exceed its long term liabilities (¥849.0M).


Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: 177A's net debt to equity ratio (13.4%) is considered satisfactory.

Borcun Azaltılması: Insufficient data to determine if 177A's debt to equity ratio has reduced over the past 5 years.

Borç Kapsamı: 177A's debt is well covered by operating cash flow (37.8%).

Faiz Kapsamı: 177A's interest payments on its debt are well covered by EBIT (27.1x coverage).


Bilanço


Sağlıklı şirketleri keşfedin